David A. Siegel Nevro Corp Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Nevro Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 502,200 shares of NVRO stock, worth $4.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
502,200
Previous 519,700
3.37%
Holding current value
$4.23 Million
Previous $11.2 Million
35.16%
% of portfolio
0.02%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding NVRO
# of Institutions
174Shares Held
37.4MCall Options Held
80.4KPut Options Held
898K-
Armistice Capital, LLC New York, NY3.62MShares$30.5 Million0.71% of portfolio
-
Black Rock Inc. New York, NY3.41MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$26.7 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$23.5 Million0.5% of portfolio
-
Fred Alger Management, LLC New York, NY2.08MShares$17.5 Million0.15% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $298M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...